3Manley H J, Cannella C A. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients[J]. Nephrol News Issues, 2005, 19(2) :27--28.
4Cranor C W, Bunting B A, Christensen D B. The Asheville Project: long term clinical and economic outcomes of a community pharmacy diabetes care program[J]. J Am Pharm Assoc, 2003,43 (2):173--184.
5National Conference of State Legislatures. Medication Therapy Management.- Pharmaceutical Safety and Savings[EB/OL]. (2010--11- 01) [2010 -12--08]. http:,//www, ncsl. org.
6McGivney M S, Meyer S M, Duncan H W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care [J]. J Am Pharm Assoc, 2007, 47(5) :620--628.
7Doucetle W R, McDonough R P, Klepser D, et al. Comprehensive medication therapy management: identifying and resolving drug related issues in a community pharmacy[J]. Clin Ther, 2005,27 (7): 1104--1111.
8Iyer R, Coderre P, Mckelvey T,et al. An employer based, pharmacist intervention model for patients with type 2 diabetes[J]. Am J Health Syst Pharm, 2010,67(2): 312--315.
9Smith S R, Catellier D J, Conlisk E A, et al. Effect on health outcomes of a community based medication therapy management pro gram for seniors with limited incomes[J]. Am J Health Syst Pharm,2006, 63 (4): 372- 379.
10Isetts B J,Schondelmeyer S W, Artz M B,et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience[J]. J Am Pharm Assoc,2008,48 (2) : 203--211.
